These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 439900)

  • 41. Breast tumor modeling for prognosis and treatment.
    Griswold DP; Corbett TH
    Recent Results Cancer Res; 1976; (57):42-58. PubMed ID: 1013511
    [No Abstract]   [Full Text] [Related]  

  • 42. Remissions of mammary adenocarcinoma in hypothyroid mice given 5-fluorouracil and chloroquine phosphate.
    Shoemaker JP; Dagher RK
    J Natl Cancer Inst; 1979 Jun; 62(6):1575-8. PubMed ID: 286128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW; Bartlett GL; Purnell DM; Webb S
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide.
    Kundu N; Dorsey R; Jackson MJ; Guiterrez P; Wilson K; Fu S; Ramanujam K; Thomas E; Fulton AM
    Int J Cancer; 1998 May; 76(5):713-9. PubMed ID: 9610731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P
    Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapy with siRNA for Vegf-c but not for Vegf-d suppresses wide-spectrum organ metastasis in an immunocompetent xenograft model of metastatic mammary cancer.
    Shibata MA; Shibata E; Morimoto J; Harada-Shiba M
    Anticancer Res; 2013 Oct; 33(10):4237-47. PubMed ID: 24122987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors.
    Addison CL; Bramson JL; Hitt MM; Muller WJ; Gauldie J; Graham FL
    Gene Ther; 1998 Oct; 5(10):1400-9. PubMed ID: 9930346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
    Thomson AW; Cruickshank N; Fowler EF
    Br J Cancer; 1979 May; 39(5):598-602. PubMed ID: 486317
    [No Abstract]   [Full Text] [Related]  

  • 49. Influence of age on induction of mammary tumors by diethylstilbestrol in C3H/HeN mice with low murine mammary tumor virus titer.
    Greenman DL; Highman B; Chen JJ; Schieferstein GJ; Norvell MJ
    J Natl Cancer Inst; 1986 Oct; 77(4):891-8. PubMed ID: 3020299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of abdominal transplanted mammary tumor on peritoneal fluid cytology in mice.
    Davis RH; Sackman JW; Kramer DL; Balin H
    Obstet Gynecol; 1975 Feb; 45(2):190-2. PubMed ID: 1118092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of surgery, irradiation, chemotherapy, and immunotherapy on growth of a metastasizing rat mammary adenocarcinoma.
    Bogden AE; Esber HJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):97-100. PubMed ID: 748802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of radiofrequency hyperthermia on the Ca755 murine adenocarcinoma.
    Slotman GJ; Milazzo J; Jain K; Swaminathan AP; Rush BF
    Cancer; 1980 Nov; 46(9):1992-5. PubMed ID: 7427906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of maltose tetrapalmitate on tumor vascularization and tumor growth.
    Benrezzak O; Bissonnette E; Madarnas P; Nigam VN
    Anticancer Res; 1989; 9(6):1815-8. PubMed ID: 2483306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced lymphocytic action on breast tumor.
    Davidson AT
    J Natl Med Assoc; 1974 Nov; 66(6):472-4. PubMed ID: 4436878
    [No Abstract]   [Full Text] [Related]  

  • 56. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL
    J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time.
    Ahmed M; Lukyanov AN; Torchilin V; Tournier H; Schneider AN; Goldberg SN
    J Vasc Interv Radiol; 2005 Oct; 16(10):1365-71. PubMed ID: 16221908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.
    Torrado E; Adusumilli S; Fraga AG; Small PL; Castro AG; Pedrosa J
    Infect Immun; 2007 Aug; 75(8):3979-88. PubMed ID: 17517872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The influence of dietary fat and non-specific immunotherapy on carcinogen-induced rat mammary adenocarcinoma.
    Kollmorgen GM; King MM; Roszel JF; Daggs BJ; Longley RE
    Vet Pathol; 1981 Jan; 18(1):82-91. PubMed ID: 6781126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.